Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)

INTRODUCTION: Multiple sclerosis (MS) is an autoimmune disorder with large annual costs. This study evaluated utilization and costs for the management of MS relapses with H.P. Acthar(®) Gel (repository corticotropin injection; Acthar; Mallinckrodt) compared to receipt of plasmapheresis (PMP) or intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Laura S., Suh, Kangho, Schepman, Patricia B., Damal, Kavitha, Hansen, Ryan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969319/
https://www.ncbi.nlm.nih.gov/pubmed/27312977
http://dx.doi.org/10.1007/s12325-016-0363-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969319/
https://www.ncbi.nlm.nih.gov/pubmed/27312977
http://dx.doi.org/10.1007/s12325-016-0363-0

Ejemplares similares